Polycystic ovarian syndrome - prognosis and outcomes
Date
2006
Authors
Hart, R.
Norman, R.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Best Practice and Research: Clinical Obstetrics and Gynaecology, 2006; 20(5):751-778
Statement of Responsibility
Roger Hart and Robert Norman
Conference Name
Abstract
Polycystic ovarian syndrome (PCOS) is a condition that is present in 5–6% of women of reproductive age. It has potentially profound implications for women with regard to anovulatory infertility and symptoms related to elevated androgen levels. In addition, in later life women are prone to significant health problems related to hyperinsulinaemia, with an excess risk for diabetes and cardiovascular risk factors. Evidence suggests that the adverse features of PCOS can be ameliorated with lifestyle intervention, such as diet and exercise, while further short-term benefits related to ovulation and cardiac risk factors may be derived from medication with metformin. Evidence for the long-term use of metformin to protect against adverse cardiovascular outcomes and for the use of metformin throughout pregnancy to reduce the risk of miscarriage, gestational diabetes, pre-eclampsia and fetal macrosomia is still lacking. Key words: PCOS; metabolic syndrome; infertility; diabetes; cardiovascular risk; metformin; androgens
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2006 Elsevier Ltd All rights reserved.